Rosacea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

July 2020 | 104 pages | ID: RFF6AF69B165EN
VPAResearch

Abstracts

2020 Rosacea PIPELINE HIGHLIGHTS
Rosacea is one of the widely researched conditions during 2020 with 21 companies actively focusing on realizing pipeline’s potential. Development of Rosacea medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Global Rosacea market presents promising new product pipeline with NME Projects, pivotal trials, and rapidly phase-advancing therapeutic candidates. Increasing number of companies are assessing the feasibility of developing treatment options for Rosacea.

Good progress is anticipated during 2020 and 2021 with Rosacea pipeline molecules advancing from pre-clinical investigation to completion of advanced Phase clinical trials. Rosacea pipeline continues to expand and progress with novel mechanisms and diverse routes of administration being tested by companies.
Rosacea DRUG DEVELOPMENT PIPELINE OVERVIEW
The “Rosacea pipeline Research Monitor, 2020” report is an analytical research study on the progress achieved by pipeline companies during the year along with its historical development, current status, and outlook.
This Rosacea pipeline review explores high-potential early to late-stage pipeline projects with a continued focus on new insights, accelerated processes, and pipeline progression.

The competitive intelligence report on Rosacea presents detailed insights into therapeutic drug pipeline development, industry news, deals, and analysis across the length and breadth of the Rosacea pipeline. Information on R&D pipeline updates, results of key clinical trials are also included in the report.
Rosacea DRUG PROFILES
Rosacea development pipeline including projects in early- and late-stage development are detailed in the report. Details of clinical trial data and submissions to regulatory authorities are also provided. For the drug candidates included in the report, the following information is provided-

• Current Status of Development including phase advancements, regulatory approvals of phases, acquisitions, licensing and technology transfers, product launches in various markets, and others.
• Phase of development
• Mechanism of Action
• Route of Administration
• Companies involved including originator, licensing companies, developer, investors, and others
• New molecular entity details
• Orphan drug designation and other special status provided by regulators

Rosacea COMPANY PROFILES

Both small size and large size pharmaceutical companies are investing their resources in Rosacea drug development operations. Further, financial institutions are extending support to small pharmaceutical companies, universities, and other researchers for the development of treatment of Rosacea. Partnerships and acquisitions are also increasingly observed in the pipeline.

This research report presents an analysis of 21 Rosacea companies including company overview, key snapshot, contact information, and their strategies on accelerating Rosacea pipeline development. Mid-stage and early portfolios of these companies are analyzed in detail in the report.

Companies analyzed in the report include- Accuitis Pharmaceuticals Inc, Afecta Pharmaceuticals Inc, Aiviva BioPharma Inc, Alfasigma S.p.A., AOBiome LLC, BioMimetix JV LLC, Botanix Pharmaceuticals Ltd, Cellix Bio Pvt Ltd, Cutanea Life Sciences Inc, Dermata Therapeutics LLC, Dr Reddys Laboratories, Emeriti Pharma AB, Hovione, Maruho Co Ltd, Matrisys Bioscience Inc, Menlo Therapeutics Inc, Sol-Gel Technologies Ltd, Sunny Pharmtech Inc, Tarsus Pharmaceuticals Inc, Timber Pharmaceuticals, TWi Biotechnology Inc

REASONS TO BUY

• The current market conditions are forcing companies and investors worldwide to prioritize their investments and accelerate pipeline candidates only through careful quantitative assessment.
• This research work assists decision makers in pharmaceutical companies towards successful pipeline development through critically evaluated pipeline data
• Buyers can identify most promising drug candidates for treatment of Rosacea
• It allows users to strengthen their pipeline through acquisitions, licensing and collaborations
• Users can estimate possible delays in the delivery of pipeline or launch of new products
• Stay ahead of competition through understanding their pipeline progression, strategies and outlook
• The report details all the pipeline candidates under investigation in various stages of development from Phase I through to Phase III to enable business development managers to understand the impact of new launches.
• Optimize your licensing and technology transfer strategies through identification of prospect partners

Contents

1. INTRODUCTION TO ROSACEA

1.1 Rosacea- Disease overview
1.2 Rosacea- Market Size
1.3 Rosacea- Companies Involved

2. ROSACEA PIPELINE SNAPSHOT- 2020

2.1 Rosacea Pipeline by Phase
2.2 Rosacea Pipeline by Mechanism of Action
2.3 Rosacea Pipeline by Route of Administration
2.4 Rosacea Pipeline- New Molecular Entities
2.5 Rosacea Pipeline- Orphan Drug Designation/ Special Designation

3. ROSACEA DRUG PROFILES

3.1 Current Status
3.2 Rosacea Drug Snapshot
3.3 Rosacea Therapeutic Candidates- Originator/Licensor
3.4 Route of Administration
3.5 Mechanism of Action
3.6 NME
4.1 Accuitis Pharmaceuticals Inc Rosacea Pipeline Insights and Clinical Trials
4.2 Afecta Pharmaceuticals Inc Rosacea Pipeline Insights and Clinical Trials
4.3 Aiviva BioPharma Inc Rosacea Pipeline Insights and Clinical Trials
4.4 Alfasigma S.p.A. Rosacea Pipeline Insights and Clinical Trials
4.5 AOBiome LLC Rosacea Pipeline Insights and Clinical Trials
4.6 BioMimetix JV LLC Rosacea Pipeline Insights and Clinical Trials
4.7 Botanix Pharmaceuticals Ltd Rosacea Pipeline Insights and Clinical Trials
4.8 Cellix Bio Pvt Ltd Rosacea Pipeline Insights and Clinical Trials
4.9 Cutanea Life Sciences Inc Rosacea Pipeline Insights and Clinical Trials
4.10 Dermata Therapeutics LLC Rosacea Pipeline Insights and Clinical Trials
4.11 Dr Reddys Laboratories Rosacea Pipeline Insights and Clinical Trials
4.12 Emeriti Pharma AB Rosacea Pipeline Insights and Clinical Trials
4.13 Hovione Rosacea Pipeline Insights and Clinical Trials
4.14 Maruho Co Ltd Rosacea Pipeline Insights and Clinical Trials
4.15 Matrisys Bioscience Inc Rosacea Pipeline Insights and Clinical Trials
4.16 Menlo Therapeutics Inc Rosacea Pipeline Insights and Clinical Trials
4.17 Sol-Gel Technologies Ltd Rosacea Pipeline Insights and Clinical Trials
4.18 Sunny Pharmtech Inc Rosacea Pipeline Insights and Clinical Trials
4.19 Tarsus Pharmaceuticals Inc Rosacea Pipeline Insights and Clinical Trials
4.20 Timber Pharmaceuticals Rosacea Pipeline Insights and Clinical Trials
4.21 TWi Biotechnology Inc Rosacea Pipeline Insights and Clinical Trials

5. ROSACEA MARKET NEWS AND UPDATES

6. APPENDIX

6.1 Sources and Methodology
6.2 Contact Information